RALEIGH, NC – May 3, 2006 – INC Research announced today that the company has expanded into additional square footage in both its global headquarters facility in Raleigh, North Carolina and in its Austin, Texas facility. The expansion is to accommodate the current and projected growth of the business. Recently, the company also expanded its European operations with the opening of new offices in France, Russia and Ukraine.
An agreement was recently signed for an additional 29,000 square feet of space in a location adjacent to the current 60,000 square foot facility that serves as global headquarters for INC Research in Raleigh. It is anticipated the company will increase its headquarters workforce by at least 50% this year.
In the same timeframe, an agreement was signed for an additional 6,000 square feet of space for the Austin facility. INC Research now occupies the entire building located at 3321 Bee Caves Road. Headcount at the Austin facility has increased by over 50% in the last 12 months.
“The aggressive growth of INC Research continues to validate our model as a premier, customer-centric service company which is therapeutically-focused and supported by advanced technology,” stated Jim Ogle, CEO of INC Research.
Mr. Ogle continued, “To date, the key to our success is the support our customers have learned to expect from our high performance teams in reaching their program objectives. The experience and depth of drug development expertise delivered to customers by the high caliber professionals at INC Research drives our growth, and will continue to do so.”
The company’s current locations, and additional facilities to be opened in the future, will continue to provide INC Research with a strategic advantage, allowing the company to tap into significant employee bases of scientific and industry expertise, and remain in close proximity to existing and future customers.